Joseph Frjelich, in Apo, AE - Physician Assistant

Joseph Frjelich, is a Physician Assistant based in Apo, Armed Forces Europe. Joseph Frjelich is licensed to practice in * (Not Available) (license number ) and his current practice location is Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, Armed Forces Europe. He can be reached at his office (for appointments etc.) via phone at (314) 590-2368.

NPI number for Joseph Frjelich is 1013373323 and his current mailing address is Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, Armed Forces Europe. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1013373323.

Contact Information

	Joseph Frjelich,
	Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112
	(314) 590-2368
	Not Available

Healthcare Provider's Profile

Full Name	Joseph Frjelich
Gender	Male
Speciality	Physician Assistant
Location	Hq Meddac Bavaria, Apo, Armed Forces Europe
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1013373323
Provider Enumeration Date: 01/04/2016
Last Update Date: 04/06/2022

Medical Identifiers

Medical identifiers for Joseph Frjelich such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013373323	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
225100000X	Physical Therapist	070.021481 (Illinois)	Secondary
363A00000X	Physician Assistant	(* (Not Available))	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Joseph Frjelich is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Joseph Frjelich, Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Ph: () -	Joseph Frjelich, Hq Meddac Bavaria, Unit 28037 Bldg 700, Apo, AE 09112 Ph: (314) 590-2368

News Archive

FDA approves Lupin Pharmaceuticals' SUPRAX for Oral Suspension

Pharma major, Lupin Ltd., announced today that its subsidiary, Lupin Pharmaceuticals Inc. (collectively, Lupin) has received approval for SUPRAX (Cefixime) for Oral Suspension, 500 mg/5mL from the United States Food and Drugs Administration (FDA).

Maryland Stem Cell Research Commission partners with NIH, NIST to host symposium on stem cell research

The Maryland Stem Cell Research Commission will host the Third Annual Maryland Stem Cell Research Symposium in partnership with the National Institutes of Health and the National Institute of Standards and Technology on Wednesday, Sept. 22, 2010.

Amarin provides progress update on MARINE and ANCHOR trials for treating elevated triglyceride levels

Amarin Corporation plc, a clinical-stage biopharmaceutical company with a focus on cardiovascular disease, today reports a financial update as of June 30, 2010. In addition, the Company provides a progress update of its MARINE and ANCHOR trials, the two on-going Phase 3 clinical trials of its lead product candidate AMR101 for treating elevated triglyceride levels.

Sinai Hospital's endocrinologist helps people to manage diabetes

Nearly 27-million people live with diabetes and 57-million more are pre-diabetic. Not only can this disease be life threatening, but it can take a huge toll on families and on those who have it- if it's not treated properly.

Positive results from Metabolex' Phase 1 MBX-2982 clinical trial for treating type 2 diabetes

Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from two multiple ascending dose Phase 1 clinical trials of MBX-2982.

Joseph Frjelich, - in Apo, AE